BR9908188A - Preparação farmacêutica, uso de um agonista de receptor de tipo 2 de angiotensina ii ou de um seu sal fisiologicamente aceitável, e, processo para tratamento e/ou prevenção de uma afecção selecionada do grupo consistindo de distúrbios do trato alimentar, tais como dispepsia, sìndrome de intestino irritável e/ou insuficiência múltipla de órgãos em um paciente - Google Patents
Preparação farmacêutica, uso de um agonista de receptor de tipo 2 de angiotensina ii ou de um seu sal fisiologicamente aceitável, e, processo para tratamento e/ou prevenção de uma afecção selecionada do grupo consistindo de distúrbios do trato alimentar, tais como dispepsia, sìndrome de intestino irritável e/ou insuficiência múltipla de órgãos em um pacienteInfo
- Publication number
- BR9908188A BR9908188A BR9908188-1A BR9908188A BR9908188A BR 9908188 A BR9908188 A BR 9908188A BR 9908188 A BR9908188 A BR 9908188A BR 9908188 A BR9908188 A BR 9908188A
- Authority
- BR
- Brazil
- Prior art keywords
- angiotensin
- type
- dyspepsia
- patient
- multiple organ
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/085—Angiotensins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Vascular Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9800550A SE9800550D0 (sv) | 1998-02-24 | 1998-02-24 | A pharmaceutical preparation comprising an angiotensin II type 2 receptor agonist, and use thereof |
| PCT/SE1999/000262 WO1999043339A1 (en) | 1998-02-24 | 1999-02-24 | A pharmaceutical preparation comprising an angiotensin ii type 2 receptor agonist, and use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9908188A true BR9908188A (pt) | 2000-10-24 |
Family
ID=20410283
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9908188-1A BR9908188A (pt) | 1998-02-24 | 1999-02-24 | Preparação farmacêutica, uso de um agonista de receptor de tipo 2 de angiotensina ii ou de um seu sal fisiologicamente aceitável, e, processo para tratamento e/ou prevenção de uma afecção selecionada do grupo consistindo de distúrbios do trato alimentar, tais como dispepsia, sìndrome de intestino irritável e/ou insuficiência múltipla de órgãos em um paciente |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP1066048A1 (xx) |
| JP (1) | JP2002504516A (xx) |
| KR (1) | KR20010041211A (xx) |
| CN (1) | CN1291104A (xx) |
| AU (1) | AU755949B2 (xx) |
| BR (1) | BR9908188A (xx) |
| CA (1) | CA2319123A1 (xx) |
| EE (1) | EE200000481A (xx) |
| HU (1) | HUP0101411A3 (xx) |
| ID (1) | ID26639A (xx) |
| IL (1) | IL137990A0 (xx) |
| IS (1) | IS5594A (xx) |
| MX (1) | MXPA00008172A (xx) |
| NO (1) | NO20004215L (xx) |
| NZ (1) | NZ506188A (xx) |
| SE (1) | SE9800550D0 (xx) |
| SK (1) | SK11522000A3 (xx) |
| WO (1) | WO1999043339A1 (xx) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001043761A2 (en) * | 1999-12-16 | 2001-06-21 | University Of Southern California | Methods for treating and preventing damage to mucosal tissue |
| US6821953B1 (en) | 1999-12-16 | 2004-11-23 | University Of Southern California | Methods for treating and preventing damage to mucosal tissue |
| CA2449150C (en) | 2001-05-31 | 2011-07-12 | Vicore Pharma Ab | Tricyclic compounds useful as angiotensin ii agonists |
| IN2014DN02217A (xx) | 2005-04-12 | 2015-07-10 | Vicore Pharma Ab | |
| US8080571B2 (en) | 2005-04-12 | 2011-12-20 | Vicore Pharma Ab | Tricyclic angiotensin II agonists |
| MX2007012635A (es) | 2005-04-12 | 2008-01-11 | Vicore Pharma Ab | Nuevos agonistas de angiotensina ii triciclica. |
| CA2882445A1 (en) * | 2005-12-14 | 2007-06-21 | Ambrx, Inc. | Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides |
| US8835471B2 (en) | 2010-06-11 | 2014-09-16 | Vicore Pharma Ab | Use of angiotensin II agonists |
| EP2455388A1 (en) | 2010-11-23 | 2012-05-23 | LanthioPep B.V. | Novel angiotensin type 2 (AT2) receptor agonists and uses thereof. |
| WO2013158628A1 (en) * | 2012-04-16 | 2013-10-24 | New York University | Modulation of angiotensin ii peceptors for the prevention and treatment of cerebral malaria |
| MX2017010993A (es) | 2015-03-02 | 2018-04-11 | Vicore Pharma Ab | Agonista del receptor de angiotensina ii para tratar la fibrosis pulmonar. |
| WO2017221012A1 (en) | 2016-06-21 | 2017-12-28 | Vicore Pharma Ab | Methods and compositions for preventing or reducing the risk of cancer treatment-related cardiotoxicity |
| GB201818164D0 (en) | 2018-11-07 | 2018-12-19 | Vicore Pharma Ab | New composition |
| CN114514032A (zh) | 2019-08-02 | 2022-05-17 | 兰提欧派普有限公司 | 用于治疗癌症的血管紧张素2型(at2)受体激动剂 |
| GB201913603D0 (en) | 2019-09-20 | 2019-11-06 | Vicore Pharma Ab | New compounds |
| KR20230004501A (ko) | 2020-03-19 | 2023-01-06 | 바이코어 파마 아베 | 안지오텐신 ⅱ와 관련된 질병, 장애, 또는 병태의 치료 및/또는 예방에 유용한 신규 화합물 |
| GB202004094D0 (en) | 2020-03-20 | 2020-05-06 | Vicore Pharma Ab | New compounds and uses |
| GB202006074D0 (en) | 2020-04-24 | 2020-06-10 | Vicore Pharma Ab | New composition |
| GB202006079D0 (en) | 2020-04-24 | 2020-06-10 | Vicore Pharma Ab | New composition |
| GB202006081D0 (en) | 2020-04-24 | 2020-06-10 | Vicore Pharma Ab | New composition |
| GB202013721D0 (en) | 2020-09-01 | 2020-10-14 | Vicore Pharma Ab | New compounds |
| GB202104033D0 (en) | 2021-03-23 | 2021-05-05 | Vicore Pharma Ab | New compounds |
| WO2022200785A1 (en) | 2021-03-23 | 2022-09-29 | Vicore Pharma Ab | Selective angiotensin ii receptor ligands |
| GB202104038D0 (en) | 2021-03-23 | 2021-05-05 | Vicore Pharma Ab | New compounds |
| WO2023281271A1 (en) | 2021-07-09 | 2023-01-12 | Vicore Pharma Ab | New selective angiotensin ii compounds |
| GB202115303D0 (en) | 2021-10-25 | 2021-12-08 | Vicore Pharma Ab | New formulation |
| MX2024009751A (es) | 2022-02-10 | 2024-08-19 | Vicore Pharma Ab | Uso de buloxibutida para el tratamiento de la fibrosis pulmonar idiopatica. |
| GB202201723D0 (en) | 2022-02-10 | 2022-03-30 | Vicore Pharma Ab | New use |
| WO2023193733A1 (zh) | 2022-04-06 | 2023-10-12 | 武汉人福创新药物研发中心有限公司 | 一种at2r激动剂 |
| WO2024133942A1 (en) | 2022-12-22 | 2024-06-27 | Vicore Pharma Ab | A method of treating a patient diagnosed with an interstitial lung disease |
| WO2024149712A1 (en) | 2023-01-09 | 2024-07-18 | Vicore Pharma Ab | Selective angiotensin ii compounds |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5444067A (en) * | 1993-08-30 | 1995-08-22 | Merck & Co., Inc. | Pharmaceutical treatment methods using angiotensin II receptor agonists bearing a thiophene moiety |
| WO1996014060A1 (en) * | 1994-11-04 | 1996-05-17 | Marklund Stefan L | Use of receptor agonists to stimulate superoxide dismutase activity |
| SE9501881D0 (sv) * | 1995-05-19 | 1995-05-19 | Astra Ab | New pharmacological use of AII-receptor antagonists |
| US5834432A (en) * | 1995-06-06 | 1998-11-10 | The University Of Southern California | Use of angiotensin II Type 2 receptor agonists in tissue repair |
| SE9502219D0 (sv) * | 1995-06-19 | 1995-06-19 | Astra Ab | Novel medical use |
-
1998
- 1998-02-24 SE SE9800550A patent/SE9800550D0/xx unknown
-
1999
- 1999-02-24 NZ NZ506188A patent/NZ506188A/xx unknown
- 1999-02-24 BR BR9908188-1A patent/BR9908188A/pt not_active IP Right Cessation
- 1999-02-24 EE EEP200000481A patent/EE200000481A/xx unknown
- 1999-02-24 CA CA002319123A patent/CA2319123A1/en not_active Abandoned
- 1999-02-24 JP JP2000533135A patent/JP2002504516A/ja active Pending
- 1999-02-24 EP EP99908017A patent/EP1066048A1/en not_active Withdrawn
- 1999-02-24 ID IDW20001909A patent/ID26639A/id unknown
- 1999-02-24 KR KR1020007009295A patent/KR20010041211A/ko not_active Application Discontinuation
- 1999-02-24 SK SK1152-2000A patent/SK11522000A3/sk unknown
- 1999-02-24 WO PCT/SE1999/000262 patent/WO1999043339A1/en not_active Application Discontinuation
- 1999-02-24 MX MXPA00008172A patent/MXPA00008172A/es unknown
- 1999-02-24 AU AU27537/99A patent/AU755949B2/en not_active Ceased
- 1999-02-24 IL IL13799099A patent/IL137990A0/xx unknown
- 1999-02-24 HU HU0101411A patent/HUP0101411A3/hu unknown
- 1999-02-24 CN CN99803230A patent/CN1291104A/zh active Pending
-
2000
- 2000-08-21 IS IS5594A patent/IS5594A/is unknown
- 2000-08-23 NO NO20004215A patent/NO20004215L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ID26639A (id) | 2001-01-25 |
| NZ506188A (en) | 2003-04-29 |
| HUP0101411A2 (hu) | 2002-03-28 |
| SE9800550D0 (sv) | 1998-02-24 |
| JP2002504516A (ja) | 2002-02-12 |
| CA2319123A1 (en) | 1999-09-02 |
| CN1291104A (zh) | 2001-04-11 |
| KR20010041211A (ko) | 2001-05-15 |
| AU755949B2 (en) | 2003-01-02 |
| EE200000481A (et) | 2002-02-15 |
| SK11522000A3 (sk) | 2001-04-09 |
| IL137990A0 (en) | 2001-10-31 |
| WO1999043339A1 (en) | 1999-09-02 |
| HUP0101411A3 (en) | 2002-11-28 |
| IS5594A (is) | 2000-08-21 |
| EP1066048A1 (en) | 2001-01-10 |
| AU2753799A (en) | 1999-09-15 |
| NO20004215L (no) | 2000-09-18 |
| NO20004215D0 (no) | 2000-08-23 |
| MXPA00008172A (es) | 2002-06-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9908188A (pt) | Preparação farmacêutica, uso de um agonista de receptor de tipo 2 de angiotensina ii ou de um seu sal fisiologicamente aceitável, e, processo para tratamento e/ou prevenção de uma afecção selecionada do grupo consistindo de distúrbios do trato alimentar, tais como dispepsia, sìndrome de intestino irritável e/ou insuficiência múltipla de órgãos em um paciente | |
| Nimmo et al. | Pharmacological modification of gastric emptying: effects of propantheline and metoclopromide on paracetamol absorption | |
| Schilström et al. | Nicotine and food induced dopamine release in the nucleus accumbens of the rat: putative role of α7 nicotinic receptors in the ventral tegmental area | |
| US8455458B2 (en) | Composition and method for treating connective tissue damage | |
| Bremell et al. | Outbreak of spontaneous staphylococcal arthritis and osteitis in mice | |
| Plumet et al. | Bacteriophage therapy for Staphylococcus aureus infections: a review of animal models, treatments, and clinical trials | |
| Richards et al. | The influence of muscle flap coverage on the repair of devascularized tibial cortex: an experimental investigation in the dog | |
| E BURKE | Heterotopic bone formation in thermal burns | |
| Kavaliers et al. | IgG from antiserum against endogenous mammalian FMRF-NH2-related peptides augments morphine-and stress-induced analgesia in mice | |
| Rabinowitz et al. | The effect of clozapine on saliva flow rate: a pilot study | |
| BR9908030A (pt) | Composição farmacêutica compreendendo uma ou mais unidades de dose oralmente ministráveis, e, processos para prepará-la, para uso da mesma, e para tratar uma condição ou distúrbio médico em um indivìduo em que tratamento com um inibidor da ciclooxigenase-2 é indicado | |
| AU645023B2 (en) | Compositions and method for treating painful, inflammatory or allergic disorders | |
| JPH04235135A (ja) | 医薬組成物 | |
| BRPI0317463B8 (pt) | composto, composição farmacêutica compreendendo o mesmo e uso do referido composto no preparo de um medicamento para tratar uma doença amilóide de transtiretina | |
| Andrews et al. | Increased 5-HT release mediates the anxiogenic response during benzodiazepine withdrawal: a review of supporting neurochemical and behavioural evidence | |
| CZ286202B6 (cs) | Farmaceutický přípravek | |
| GB2385524A (en) | Compositions and methods of use for extracts of magnoliaceae | |
| BR0112661A (pt) | Nova combinação de agonista (5ht2) e antagonista (5ht6) da serotonina como formulação farmacêutica | |
| BR9713141A (pt) | Composição farmcêutica processo e kit para o tratamento ou a prevenção de um quadro fisiológico asociado com um distúrbio isquêmico relacionado com trombose e um paciente, uso de quantidades farmaceuticamente efetivas de um composto com atividade anti-xa e de um composto antagonista de agregação de plaquetas, produto contendo estes compostos, e, uso destes compostos. | |
| WO2008157771A1 (en) | Composition and method for treating connective tissue damage by transmucosal administration | |
| Shanks et al. | Norepinephrine and serotonin alterations following chronic stressor exposure: mouse strain differences | |
| Griffin et al. | Pauciarticular arthritis in children | |
| US5929035A (en) | Methods of treating intestinal disorders | |
| US6544565B2 (en) | Use of Valeriana for the treatment of Restless Leg Syndrome and related disorders | |
| Meyendorff et al. | Methylphenidate infusion in euthymic bipolars: effect of carbamazepine pretreatment |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25A | Requested transfer of rights approved |
Free format text: PHARMACORE AB (SE) |
|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTA A 6O, 7O E 8O ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1911 DE 21/08/2007. |